Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
278.23B
Market cap278.23B
Price-Earnings ratio
18.11
Price-Earnings ratio18.11
Dividend yield
1.98%
Dividend yield1.98%
Average volume
26.01M
Average volume26.01M
High today
$64.25
High today$64.25
Low today
$62.03
Low today$62.03
Open price
$63.44
Open price$63.44
Volume
28.01M
Volume28.01M
52 Week high
$93.80
52 Week high$93.80
52 Week low
$43.08
52 Week low$43.08

NVO News

Simply Wall St 12h
Novo Nordisk Valuation Check After Mixed Returns And Undervalued Narrative

Advertisement What Novo Nordisk’s recent performance data tells you Novo Nordisk (NYSE:NVO) has posted mixed return figures, with the share price roughly flat...

Novo Nordisk Valuation Check After Mixed Returns And Undervalued Narrative
24/7 Wall St. 23h
VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The VanEck Pharm...

TipRanks 23h
Novo Nordisk Stock Gains on Obesity Pill Demand as Goldman Flags Earnings Upside

Danish drugmaker Novo Nordisk’s (NVO) shares rose about 3% as data showed that over 18,000 prescriptions were issued in the first week of the launch of the Wego...

Analyst ratings

52%

of 33 ratings
Buy
51.5%
Hold
36.4%
Sell
12.1%

More NVO News

Benzinga 1d
Novo's 500% Pill Pop: Wegovy Just Obliterated Every GLP-1 Launch Record

Novo Nordisk A/S' (NYSE:NVO) weight-loss revolution just swallowed a record. In just its second week on the market, Novo Nordisk's oral Wegovy pill hit 20,371 p...

Novo's 500% Pill Pop: Wegovy Just Obliterated Every GLP-1 Launch Record
CNBC 1d
What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Key Points Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment...

What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Simply Wall St 1d
End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health

In recent days, Hims & Hers Health ended its key pharmaceutical partnership with Novo Nordisk, losing access to branded GLP-1 weight-loss drugs and shifting emp...

End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health
TipRanks 1d
Eli Lilly, Novo Nordisk Set for Fierce Battle in India’s Obesity Drug Market as Sun Pharma Wins Wegovy Generic Nod

Pharma giants Eli Lilly (LLY) and Novo Nordisk (NVO) will face further competition in the crucial obesity drug market in India, as the country’s top drugmaker S...

Simply Wall St 2d
Novo Nordisk Advances Diabetes And Obesity Portfolio As Valuation Looks Attractive

Novo Nordisk (NYSE:NVO) has expanded its partnership with Aspect Biosystems to advance cell-based treatments for diabetes. The company has launched an oral ver...

Novo Nordisk Advances Diabetes And Obesity Portfolio As Valuation Looks Attractive
TipRanks 2d
Novo Nordisk’s Next Move in Diabetes: New CagriSema Injection Devices Enter Phase 2

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Novo Nordisk Tests New CagriSema Injection Devices in T...

TipRanks 2d
Novo Nordisk Advances CagriSema Device Study, Reinforcing Its Obesity Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.